FY2026 Earnings Forecast for Plexus Issued By Zacks Research

Plexus Corp. (NASDAQ:PLXS) – Stock analysts at Zacks Research lifted their FY2026 earnings per share (EPS) estimates for shares of Plexus in a report issued on Wednesday, August 12th. Zacks Research analyst Team now forecasts that the technology company will earn $7.02 per share for the year, up from their prior forecast of $5.87. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Plexus’ current full-year earnings is $6.73 per share. Zacks Research also issued estimates for Plexus’ Q4 2026 earnings at $2.22 EPS, Q1 2027 earnings at $2.05 EPS, Q2 2027 earnings at $2.04 EPS, Q3 2027 earnings at $2.16 EPS, Q4 2027 earnings at $2.26 EPS, FY2027 earnings at $8.50 EPS, Q1 2028 earnings at $2.26 EPS, Q2 2028 earnings at $2.26 EPS, Q3 2028 earnings at $2.38 EPS and FY2028 earnings at $9.42 EPS.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The firm had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period last year, the firm posted $1.64 earnings per share. The business’s revenue for the quarter was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS.

Other equities research analysts have also issued research reports about the company. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a research report on Friday, July 31st. Needham & Company LLC raised their price objective on Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a research report on Monday, June 1st. Weiss Ratings lowered Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Raymond James Financial reissued an “outperform” rating and set a $275.00 target price on shares of Plexus in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $273.00.

Plexus Trading Down 2.9%

Shares of NASDAQ PLXS opened at $264.04 on Friday. The stock has a market cap of $7.06 billion, a P/E ratio of 38.94 and a beta of 0.90. Plexus has a 52-week low of $126.86 and a 52-week high of $307.06. The firm has a 50 day moving average price of $272.53 and a two-hundred day moving average price of $240.12. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49.

Insider Buying and Selling

In other Plexus news, Director Michael V. Schrock sold 4,000 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the transaction, the director directly owned 40,329 shares in the company, valued at approximately $11,090,475. This represents a 9.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael J. Running sold 510 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $272.17, for a total value of $138,806.70. Following the transaction, the insider owned 665 shares in the company, valued at $180,993.05. The trade was a 43.40% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 9,510 shares of company stock valued at $2,625,182 over the last 90 days. Company insiders own 1.78% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Hodges Capital Management Inc. raised its holdings in Plexus by 47.7% during the fourth quarter. Hodges Capital Management Inc. now owns 17,950 shares of the technology company’s stock worth $2,639,000 after buying an additional 5,795 shares during the last quarter. Louisiana State Employees Retirement System acquired a new position in shares of Plexus during the first quarter valued at about $2,410,000. Jefferies Financial Group Inc. acquired a new position in shares of Plexus during the fourth quarter valued at about $2,182,000. GSA Capital Partners LLP increased its position in shares of Plexus by 159.6% during the fourth quarter. GSA Capital Partners LLP now owns 14,638 shares of the technology company’s stock worth $2,152,000 after acquiring an additional 8,999 shares in the last quarter. Finally, Inspire Investing LLC increased its position in shares of Plexus by 239.5% during the first quarter. Inspire Investing LLC now owns 10,789 shares of the technology company’s stock worth $2,185,000 after acquiring an additional 7,611 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus News Roundup

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Zacks sharply raised earnings forecasts. Zacks lifted its FY2026 EPS estimate to $7.02 from $5.87, FY2027 to $8.50 from $6.55, and FY2028 to $9.42 from $8.31. The firm also increased several quarterly forecasts, including Q4 2026 EPS to $2.22 from $1.45 and Q3 2027 EPS to $2.16 from $1.49. These revisions signal stronger expected profitability and support the bullish case for PLXS. Earnings Estimates Rising for Plexus
• Positive Sentiment: Recent operating results exceeded expectations. Plexus reported quarterly EPS of $2.32 versus the $2.13 consensus estimate, while revenue reached $1.30 billion, above the $1.23 billion forecast and up 28.2% year over year. The company also issued Q4 2026 EPS guidance of $2.47–$2.63.
• Positive Sentiment: Analyst sentiment remains favorable. Plexus carries a consensus “Buy” rating, with recent target increases including Stifel’s $330 target and Needham’s $310 target. Institutional ownership is also high at approximately 94.45%.
• Negative Sentiment: A director sold $1.1 million of stock. Director Michael Schrock sold 4,000 shares at $275, reducing his holdings by 9.02%. The transaction occurred under a pre-arranged Rule 10b5-1 plan, which makes it a less concerning signal, but it may still weigh on sentiment. Insider Selling: Plexus Director Sells Stock

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.